谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Stage IV Renal Cell Carcinoma Achieves Pathologic Complete Response after Two Ipilimumab Plus Nivolumab Courses Despite Severe Immune-Related Adverse Events: a Case Report

Ryo Takada, Miki Fujiwara,Masatoshi Maki, Naoyuki Nomura, Shintaro Kono, Akira Fujita, Hiroshi Masumoto, Yoko Takahashi,Yasuhisa Hasegawa,Koji Tamura

Journal of pharmaceutical health care and sciences（2024）

引用 0|浏览8
暂无评分
关键词
Renal cell carcinoma,Immune checkpoint inhibitors,Ipilimumab,Nivolumab,irAEs
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要